The antitumoral effect of the long-acting somatostatin analog lanreotide in neuroendocrine tumors.
Ducreux M, Ruszniewski P, Chayvialle JA, Blumberg J, Cloarec D, Michel H, Raymond JM, Dupas JL, Gouerou H, Jian R, Genestin E, Hammel P, Rougier P.
Ducreux M, et al. Among authors: ruszniewski p.
Am J Gastroenterol. 2000 Nov;95(11):3276-81. doi: 10.1111/j.1572-0241.2000.03210.x.
Am J Gastroenterol. 2000.
PMID: 11095353
Clinical Trial.